Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.

Journal of Surgical Oncology
Takamaru AshikagaNational Surgical Adjuvant Breast, Bowel Project

Abstract

Three year post-surgical morbidity levels were compared between patients with negative sentinel lymph node dissection alone (SLND) and those with negative sentinel node dissection and negative axillary lymph node dissection (ALND) in the NSABP B-32 trial. A total of 1,975 ALND and 2,008 SLND node negative breast cancer patients had shoulder range of motion and arm volumes assessed along with self reports of arm tingling and numbness. Relative shoulder abduction deficits and relative arm volume differences between ipsilateral and contralateral arms were calculated. Shoulder abduction deficits >or=10% peaked at 1 week for the ALND (75%) and SLND (41%) groups. Arm volume differences >or=10% at 36 months were evident for the ALND (14%) and SLND (8%) groups. Numbness and tingling peaked at 6 months for the ALND (49%, 23%) and SLND (15%, 10%) groups. Logistic regression correlates of residual morbidity included treatment group, age, handedness, tumor size, systemic chemotherapy, and radiation to the axilla. Although residual morbidity for both treatment groups was evident, the results of the NSABP B-32 study indicate the superiority of the SLND compared to the ALND treatment approach relative to post-surgical morbidity outcomes over ...Continue Reading

References

Jan 1, 1997·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·F P Luyten
Aug 9, 2003·The New England Journal of Medicine·Umberto VeronesiRoberto Gennari
Apr 20, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lyn KligmanNancy S Laetsch
Jul 5, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anand David PurushothamStephen William Duffy
Jul 7, 2007·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·P Del BiancoUNKNOWN GIVOM
Dec 4, 2008·Annals of Surgical Oncology·Grantley Gill, UNKNOWN SNAC Trial Group of the Royal Australasian College of Surgeons (RACS) and NHMRC Clinical Trials Centre
Apr 15, 2009·Annals of Surgical Oncology·Rebecca J TsaiCarol Scott-Conner
Oct 1, 2009·Breast Cancer Research and Treatment·L BordeleauP Goodwin

❮ Previous
Next ❯

Citations

Jul 12, 2011·Breast Cancer Research and Treatment·Zhen WangJun-Qiang Chen
Apr 25, 2012·Breast Cancer Research and Treatment·Ellen W LevyNicole L Stout
Nov 28, 2012·Current Treatment Options in Oncology·Lisa C KlepczykJennifer F De Los Santos
Oct 20, 2010·Current Oncology Reports·Randal L CroshawThomas B Julian
Feb 12, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xiaowen DingHongjian Yang
Oct 1, 2013·The Breast : Official Journal of the European Society of Mastology·Birgitte Vrou OffersenJens Overgaard
Oct 27, 2012·Japanese Journal of Clinical Oncology·Peng-fei QiuZhao-peng Zhang
Dec 21, 2012·Current Opinion in Obstetrics & Gynecology·Amer Karam
May 13, 2014·PloS One·Janine T HiddingMaria W G Nijhuis-van der Sanden
Jan 15, 2011·Pathology Research International·Georgios PechlivanidesStamatis Vasilaros
Jan 10, 2012·ISRN Oncology·Susan HooverSunil Patel
Feb 6, 2014·Breast Cancer Research and Treatment·Hanne VerbelenWiebren Tjalma
Mar 29, 2014·World Journal of Surgical Oncology·Emerson Wander Silva SoaresGéser Vinícius Silva Soares
Feb 6, 2014·Archives of Gynecology and Obstetrics·Sebastian M JudAlexander Hein
Jun 3, 2014·Surgical Oncology Clinics of North America·Ashley C McGinityIsmail Jatoi
Dec 15, 2012·Current Treatment Options in Oncology·N BijkerE J Th Rutgers
Dec 3, 2014·Surgery·Daniela OchoaV Suzanne Klimberg
Nov 21, 2014·Lymphatic Research and Biology·Mi-Joung LeeSharon Kilbreath
Sep 24, 2013·World Journal of Surgical Oncology·Pankaj TiwariStephen P Povoski
Nov 22, 2013·World Journal of Surgical Oncology·Yu-Shu ChengDar-Ren Chen
May 5, 2012·World Journal of Surgery·Ashwini KumarIsmail Jatoi
Feb 20, 2016·Annals of Surgical Oncology·Mediget TeshomeElizabeth A Mittendorf
Jun 26, 2013·Journal of the American College of Surgeons·Sarah A McLaughlin
Jun 20, 2013·Critical Reviews in Oncology/hematology·Jean O'TooleAlphonse G Taghian
Jun 4, 2013·Seminars in Nuclear Medicine·Valeria M MoncayoNaomi P Alazraki
Mar 8, 2013·The Surgical Clinics of North America·Dalliah M Black, Elizabeth A Mittendorf
Mar 8, 2013·The Surgical Clinics of North America·Barbara Zarebczan Dull, Heather B Neuman
Dec 26, 2012·Journal of the American College of Surgeons·Sarah A McLaughlinJustin Nguyen
Aug 10, 2012·Advances in Surgery·Richelle T WilliamsDavid J Winchester

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.